BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3155624)

  • 1. Phosphorylation of ventricular sarcolemmal membranes does not alter binding properties of nitrendipine.
    Hayes JS; Bowling N; Conery BG; Kauffman RF
    Biochim Biophys Acta; 1985 Jan; 812(2):313-20. PubMed ID: 3155624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydropyridine binding to the L-type Ca2+ channel in rabbit heart sarcolemma and skeletal muscle transverse-tubules: role of disulfide, sulfhydryl and phosphate groups.
    Murphy BJ; Washkurak AW; Tuana BS
    Biochim Biophys Acta; 1990 May; 1052(2):333-9. PubMed ID: 2159349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of the calcium channel blocker nitrendipine to its receptor in purified sarcolemma from canine cardiac ventricle.
    Sarmiento JG; Janis RA; Colvin RA; Triggle DJ; Katz AM
    J Mol Cell Cardiol; 1983 Feb; 15(2):135-7. PubMed ID: 6304327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of high affinity binding of calcium channel blocking drugs to vascular smooth muscle and cardiac sarcolemmal membranes.
    Sarmiento JG; Janis RA; Katz AM; Triggle DJ
    Biochem Pharmacol; 1984 Oct; 33(20):3119-23. PubMed ID: 6487362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of verapamil binding sites in cardiac membrane vesicles.
    Garcia ML; Trumble MJ; Reuben JP; Kaczorowski GJ
    J Biol Chem; 1984 Dec; 259(24):15013-6. PubMed ID: 6096353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An effect of ischemia on myocardial dihydropyridine binding sites.
    Nayler WG; Dillon JS; Elz JS; McKelvie M
    Eur J Pharmacol; 1985 Sep; 115(1):81-9. PubMed ID: 2412860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoproterenol-induced phosphorylation of a 15-kilodalton sarcolemmal protein in intact myocardium.
    Presti CF; Jones LR; Lindemann JP
    J Biol Chem; 1985 Mar; 260(6):3860-7. PubMed ID: 2982878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile of the oppositely acting enantiomers of the dihydropyridine 202-791 in cardiac preparations: receptor binding, electrophysiological, and pharmacological studies.
    Williams JS; Grupp IL; Grupp G; Vaghy PL; Dumont L; Schwartz A; Yatani A; Hamilton S; Brown AM
    Biochem Biophys Res Commun; 1985 Aug; 131(1):13-21. PubMed ID: 2412552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of binding of a calcium channel blocker to inhibition of contraction in intact cultured embryonic chick ventricular cells.
    Marsh JD; Loh E; Lachance D; Barry WH; Smith TW
    Circ Res; 1983 Oct; 53(4):539-43. PubMed ID: 6313249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation and dephosphorylation of dihydropyridine-sensitive voltage-dependent Ca2+ channel in skeletal muscle membranes by cAMP- and Ca2+-dependent processes.
    Hosey MM; Borsotto M; Lazdunski M
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3733-7. PubMed ID: 2424010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Bay k 8644, a dihydropyridine analog, on [3H]nitrendipine binding to canine cardiac sarcolemma and the relationship to a positive inotropic effect.
    Vaghy PL; Grupp IL; Grupp G; Schwartz A
    Circ Res; 1984 Oct; 55(4):549-53. PubMed ID: 6206963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes.
    Williams LT; Tremble P
    J Clin Invest; 1982 Jul; 70(1):209-12. PubMed ID: 6282938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between the negative inotropic potency and binding parameters of 1,4-dihydropyridine and phenylalkylamine calcium channel blockers in cat heart.
    Goll A; Glossmann H; Mannhold R
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):303-12. PubMed ID: 3027587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of receptor sites for [3H]nitrendipine in chick hearts and physiological relation to the slow Ca2+ channel and to excitation-contraction coupling.
    Renaud JF; Kazazoglou T; Schmid A; Romey G; Lazdunski M
    Eur J Biochem; 1984 Mar; 139(3):673-81. PubMed ID: 6321185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-affinity antibodies to the 1,4-dihydropyridine Ca2+-channel blockers.
    Campbell KP; Sharp A; Strom M; Kahl SD
    Proc Natl Acad Sci U S A; 1986 May; 83(9):2792-6. PubMed ID: 3010317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phencyclidine increases the affinity of dihydropyridine calcium channel antagonist binding in rat brain.
    Bolger GT; Rafferty MF; Skolnick P
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):227-34. PubMed ID: 2932650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrendipine: effects on vascular responses and myocardial binding.
    McBride W; Mukherjee A; Haghani Z; Wheeler-Clark E; Brady J; Gandler T; Bush L; Buja LM; Willerson JT
    Am J Physiol; 1984 Nov; 247(5 Pt 2):H775-83. PubMed ID: 6093595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Putative Ca2+ channels in cardiac membranes. Subcellular distribution of [3H]nitrendipine receptors.
    Haase H; Vetter R; Will H; Will-Shahab L
    Biomed Biochim Acta; 1986; 45(1-2):S223-6. PubMed ID: 2421716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes.
    Bellemann P; Ferry D; Lübbecke F; Glossman H
    Arzneimittelforschung; 1981; 31(12):2064-7. PubMed ID: 7199299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unmasking effect of alamethicin on the (Na+,K+)-ATPase, beta-adrenergic receptor-coupled adenylate cyclase, and cAMP-dependent protein kinase activities of cardiac sarcolemmal vesicles.
    Jones LR; Maddock SW; Besch HR
    J Biol Chem; 1980 Oct; 255(20):9971-80. PubMed ID: 6253461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.